Novatoris launches smartphone-based research into multiple sclerosis

By Laura Mullan
Share
Novatoruis is partnering with Sage Bionetworks to launch a large-scale multiple sclerosis study using data from smartphones. The study, dubbed elevateM...

Novatoruis is partnering with Sage Bionetworks to launch a large-scale multiple sclerosis study using data from smartphones.

The study, dubbed elevateMS, hopes to evaluate, in real time, the daily struggles faced by people living with MS.

The study will use an app to collect information about patient’s movement performance and symptoms from their smartphones.

RELATED STORIES:

It is hoped that the results may help researchers develop new ways to measure treatment’s effectiveness.

Designed with input from patients, neurologists and disease advocates, the study’s mobile app was built on the Apple ResearchKit platform.

Beneficially, the mobile format eliminates the need for clinic visits which broadens the population that can participate. It’s an outcome that is already pushing some oncology companies to search for digital solutions of their own as fewer potential trial participants emerge.

In a statement, Dr Stanley Cohan, medical director of the Providence Multiple Sclerosis Centre in Oregon said: “As physicians, we always want to know how our patients with MS are doing on the treatments we prescribe.

“With the elevateMS app, study participants can frequently document their symptoms in a personal health story.

“In turn, this data may provide researchers with new ways to look at disease progression and treatment effectiveness.”

The study is entitled “Evaluation of Evidence from Smart Phone Sensors and Patient-Reported Outcomes in Participants with Multiple Sclerosis (elevateMS)

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma